Top-News
Gesundheitswesen USA

Omnicell News

Aktie
WKN:  632313 ISIN:  US68213N1090 US-Symbol:  OMCL
27,20 €
-0,20 €
-0,73%
09:18:56 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
45,08 Mio.
Marktkapitalisierung *
1,23 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 09.07.2023

Omnicell News

01.09.23 - PR Newswire
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 PR Newswire
01.06.23 - PR Newswire
EmpiRx Health Names Healthcare and Technology Veteran Danny Sanchez as CEO
EmpiRx Health Names Healthcare and Technology Veteran Danny Sanchez as CEO PR Newswire
28.06.22 - PR Newswire
Omnicell, Southwestern Energy and Ormat Technologies Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
Omnicell, Southwestern Energy and Ormat Technologies Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 PR Newswire
09.12.20 - PR Newswire
Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp?
Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp? PR Newswire
13.09.19 - PR Newswire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Omnicell, Inc. (NASDAQ: OMCL) and Encourages Omnicell Investors to Contact the Firm
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Omnicell, Inc. (NASDAQ: OMCL) and Encourages Omnicell ...
24.08.19 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omnicell, Inc. - OMCL PR Newswire
02.08.19 - PR Newswire
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm PR Newswire
29.07.19 - PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Omnicell, Inc.; Encourages Investors with Over $100K in Losses to Contact the Firm - OMCL
ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Omnicell, Inc.; Encourages Investors with Over $100K in Losses to Contact the ...
26.07.19 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Acer Therapeutics Inc., Aclaris Therapeutics, Inc., Ideanomics, Inc., L Brands, Inc., Marriott International, Inc., NRC Group Holdings Corp., Omnicell, Inc., and OncoCyte Corporation
Lifshitz & Miller LLP Announces Investigation of Acer Therapeutics Inc., Aclaris Therapeutics, Inc., Ideanomics, Inc., L Brands, Inc., Marriott International, Inc., NRC Group Holdings ...
19.07.19 - PR Newswire
OMCL CLASS ACTION ALERT: Hagens Berman Alerts Omnicell (OMCL) Investors to Class Action, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm
OMCL CLASS ACTION ALERT: Hagens Berman Alerts Omnicell (OMCL) Investors to Class Action, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm PR ...
15.07.19 - PR Newswire
OMCL INVESTIGATION Update: Hagens Berman Updates Omnicell (OMCL) Investors of the Firm's Ongoing Investigation of Possible Disclosure Violations
OMCL INVESTIGATION Update: Hagens Berman Updates Omnicell (OMCL) Investors of the Firm's Ongoing Investigation of Possible Disclosure Violations PR Newswire
11.07.19 - PR Newswire
Investor Alert: Kaplan Fox Investigates Omnicell, Inc. (Nasdaq: OMCL)
Investor Alert: Kaplan Fox Investigates Omnicell, Inc. (Nasdaq: OMCL) PR Newswire
11.07.19 - PR Newswire
OMCL INVESTOR ALERT: Hagens Berman Alerts Omnicell (OMCL) Investors to Investigation of Possible Disclosure Violations
OMCL INVESTOR ALERT: Hagens Berman Alerts Omnicell (OMCL) Investors to Investigation of Possible Disclosure Violations PR Newswire
25.04.19 - PR Newswire
Omnicell Reports Results for First Quarter 2019
Omnicell Reports Results for First Quarter 2019 GAAP and non-GAAP revenues of $202.5 million, up 10.9% year-​over-year GAAP net income per diluted share of $0.08, up 14.3% ...
24.04.19 - PR Newswire
The University of Tennessee Medical Center Selects Omnicell Solutions to Support Medication Management Strategy
The University of Tennessee Medical Center Selects Omnicell Solutions to Support Medication Management Strategy New Solutions Will Help Optimize Workflows and Enhance ...
23.04.19 - PR Newswire
CaroMont Health Selects Omnicell's Industry-Leading Medication Management Portfolio to Help Improve Pharmacy Operations and Patient Care
CaroMont Health Selects Omnicell's Industry-​Leading Medication Management Portfolio to Help Improve Pharmacy Operations and Patient Care Solutions Leverage Automation to ...
22.04.19 - PR Newswire
Inova Extends Partnership with Omnicell to Enhance Efficiency and Safety in Medication Management
Inova Extends Partnership with Omnicell to Enhance Efficiency and Safety in Medication Management Automation for Sterile Compounding and Patient Care Areas Support Improved ...
18.04.19 - PR Newswire
Omnicell to Release First Quarter 2019 Earnings Results on April 25, 2019
Omnicell to Release First Quarter 2019 Earnings Results on April 25, 2019 PR Newswire
08.04.19 - PR Newswire
Omnicell Showcasing Medication Management Automation Portfolio at the American Organization of Nurse Executives 2019 Conference
Omnicell Showcasing Medication Management Automation Portfolio at the American Organization of Nurse Executives 2019 Conference Company to Feature Fully Digitized, ...
26.03.19 - PR Newswire
Omnicell Highlighting Importance of Fully Digitized, Autonomous Pharmacy Vision at European Association of Hospital Pharmacists Congress 2019
Omnicell Highlighting Importance of Fully Digitized, Autonomous Pharmacy Vision at European Association of Hospital Pharmacists Congress 2019 Company to Showcase ...

Newssuche

Videos

09:00 Uhr -3,96%
Technical Trading: 40 Prozent Chance mit diesem Trade
Erdgas Short Typ: Turbo Open End WKN: VD6GF5 Hebel: 3 Laufzeit: OpenEnd Einstieg: Market ... Mehr »